Clinical Trial

Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated May 11, 2026 (before its estimated July 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
An Exploratory Multicenter, Open-label, Sequential Cohort Study to Evaluate the Preliminary Efficacy, Safety, and Pharmacokinetic Characteristics of LP-98 for Injection in Antiretroviral Therapy-Naive HIV-Infected Individuals
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-02-24; most recent amendment 2026-05-06.
Trial Details
NCT Number NCT07433387
Lead Sponsor Shanxi Kangbao Biological Product Co., Ltd.
Collaborators: Institute of Pathogen Biology, Beijing, China
Conditions HIV
Enrollment 30 participants
Start Date 2026-01-29
Primary Completion 2026-07-10 (estimated)
Study Completion 2026-09-25 (estimated)
Updated on ClinicalTrials.gov 2026-05-11